CSL Profit Rises, Boosts Dividend
Wall Street Journal
Australia-based pharmaceuticals company CSL said its half-year statutory net profit rose by 17%, reflecting a strong performance in its main blood-plasma business.
https://www.wsj.com/articles/csl-profit-rises-boosts-dividend-9c809007